Celera Completes Split from Applera; Adds Two Directors, Plans Shift in Fiscal Year | GenomeWeb
NEW YORK (GenomeWeb News) – Celera said today that it has completed its separation from Applera and is now trading as an independent publicly traded firm on the Nasdaq exchange under the ticker symbol “CRA.”
 
Applera, meantime, has changed its name to Applied Biosystems Inc. Its stock will continue to be listed on the New York Stock Exchange under the symbol "ABI."
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.